US2021060564A1PendingUtilityA1
Fluidic devices with freeze-thaw valves with ice-nucleating agents and related methods of operation and analysis
Assignee: UNIV NORTH CAROLINA CHAPEL HILLPriority: Jul 22, 2015Filed: Nov 6, 2020Published: Mar 4, 2021
Est. expiryJul 22, 2035(~9 yrs left)· nominal 20-yr term from priority
F16K 99/0044C07K 14/195C07K 14/21B01L 2400/0677B01L 3/502738B01L 7/50C07K 14/27B01L 2300/0816F16K 2099/0084B01L 2300/1894F16K 99/0036G01N 1/42C12N 15/115F16K 99/0032C12N 2310/16
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Embodiments of the invention provide fluidic devices such as, but not limited to, microfluidic chips, with one or more freeze thaw valves (FTVs) employing one or more ice-nucleating agents (INAs), that can reliably operate to freeze at relatively higher temperatures and/or at faster rates than conventional microfluidic devices with FTV systems.
Claims
exact text as granted — not AI-modifiedThat which is claimed:
1 . A liquid buffer comprising at least one ice nucleating agent (INA), wherein the at least one INA contains a carbon atom.
2 . The liquid buffer of claim 1 , wherein the at least one INA is present in the liquid buffer in an amount in a range of 1 molecule/4 to 10 billion molecules/4.
3 . The liquid buffer of claim 1 , wherein the at least one INA is present in the liquid buffer in a concentration range of about 1 nM and about 1 mM.
4 . The liquid buffer of claim 1 , wherein the at least one INA is present in the liquid buffer in a concentration range of 10 nM to 50 nM.
5 . The liquid buffer of claim 1 , wherein the at least one INA is extracted or derived from an organism.
6 . The liquid buffer of claim 1 , wherein the at least one INA comprises an ice-nucleating protein (INP) and/or a functional fragment thereof.
7 . The liquid buffer of claim 6 , wherein the INP and/or the functional fragment thereof is encoded by a gene selected from the group consisting of: iceE, iceH, inaA, inaE, inaF, inaK, inaPb, inaQ, inaU, inaV, inaW, inaX, and inaZ, and wherein the gene is found in or obtained from an organism selected from the group consisting of: Pseudomonas syringae, Ps. fluorescens, Erwinia herbicola, E. uredovora, Pantoea ananatis , and Xanthomonas campestris.
8 . The liquid buffer of claim 1 , wherein the at least one INA comprises one or more aptamers.
9 . The liquid buffer of claim 1 , wherein the at least one INA comprises an ice-nucleating protein and/or a functional fragments thereof, an ice-nucleating nucleic acid, ice-nucleating lipid, and/or an ice-nucleating carbohydrate.
10 . The liquid buffer of claim 1 , wherein the at least one INA comprises a structure similar to ice.
11 . The liquid buffer of claim 1 , wherein the at least one INA comprises a structure that aligns water molecules into an ice-like lattice.
12 . The liquid buffer of claim 1 , wherein the liquid buffer is provided with a fluidic analysis device comprising at least one fluid channel comprising at least one freeze thaw valve.
13 . The liquid buffer of claim 1 , wherein the liquid buffer is provided with a fluidic analysis device and a liquid sealing agent for the fluidic analysis device.
14 . The liquid buffer of claim 1 , wherein the liquid buffer comprises a Tris buffer.
15 . The liquid buffer of claim 1 , wherein the liquid buffer comprises a phosphate buffer.
16 . The liquid buffer of claim 2 , wherein the liquid buffer is a liquid buffer solution comprising the liquid buffer and the at least one INA, wherein the at least one INA is diluted by 1:10 to 1:10,000, relative to the liquid buffer in the liquid buffer solution.
17 . The liquid buffer of claim 1 , wherein the liquid buffer freezes at −20° C.
18 . The liquid buffer of claim 1 , wherein the liquid buffer freezes at a temperature in a range of about −45° C. and about −20° C.Join the waitlist — get patent alerts
Track US2021060564A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.